Research
Per-IPO analyses of every U.S. priced 424B4. Recent briefs first.
ETRA — IPO pricing analysis (2026-09-19)
Electra Therapeutics priced $350,000,010 at $15.00 per share — the midpoint of its $14.00 to $16.00 marketed range — on 23,333,334 shares, slightly more than the 21.7 million originally marketed. Allocators took volum...
Read brief →FBDT — IPO pricing analysis (2026-08-20)
First Breach's August 20 debut was not a traditional IPO. No proceeds entered the company on listing day. Instead, the event served as the contractual trigger for $15,615,385 of April 2026 convertible notes — plus $30...
Read brief →